期刊文献+

造血干细胞移植治疗成人急性白血病 被引量:3

Five Cases of Adult Acute Leukemia Treatment with Hematopoietic Stem Cell Transplantation
下载PDF
导出
摘要 造血干细胞移植治疗成人急性白血病5例,包括3例第一次完全缓解(CR1)急性粒细胞白血病,1例CR1急性淋巴细胞自血病,1例急性粒细胞白血病复发。其中异基因骨髓移植(alloBMT)4例,同基因外周血造血干细胞移植(Syn-PBSCT)1例。所有病例均采用TBI+CY+CCNU作预处理。所有病例均移植成功。2例发生急性移植物抗宿主病(aGVHD),其中1例又发生慢性GVHD。1例未缓解患者移植后完全缓解,但于+69天死于间质性肺炎;3例已分别无病生存22、10和3个月;余1例(急淋)移植后12个月死于复发。结果尚提示外周血干细胞移植造血重建更快。 5 Patients with adult acute leukemia were treated with hematopoietic stein cell transplantation,including 3 cases with AML in CR1,a case with ALL in CR1,a case with AML relapse in NR. Among them 4 patients were treated with allogeneic bone marrow transplantation (allo-BMT), a patient with syngeneic peripheral blood stem cell transplantation (Syn-PBSCT). All patients were conditioned by TBI +CY +CCNU. The hemopoietic function of all patients was recovered and had confirmed engraftment. Two cases presented aGVHD,one of them also presented cGVHD. One case who was in NR achieved CR after the BMT,but the patient died from severe interstitial pneumonia in day + 69; Three patients are leukemia free survivors for 22、10 and 3 months;one case (ALL) died from relapse in 12 months post-BMT. The result also indicated that the patient with PBSCT had a quicker hematopoietic reconstitution.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1997年第4期294-297,共4页 Chinese Journal of Clinical Oncology
关键词 白血病 急性 造血干细胞移植 骨髓移植 PBSCT BMT leukemia acute/therapy
  • 相关文献

参考文献4

共引文献7

同被引文献35

  • 1刘启发,张钰,魏永强,徐丹,孙竞,徐兵,刘晓力,冯茹,孟凡义,周淑芸.造血干细胞移植治疗恶性血液病疗效分析[J].肿瘤防治研究,2004,31(6):356-358. 被引量:4
  • 2王方方,何明生.慢性粒细胞白血病与格列卫耐药关系的研究[J].医学综述,2005,11(1):46-48. 被引量:2
  • 3马军,展昭民,曹峰林,孙国勋,陈立君,刘正贤,张伟杰.异基因骨髓移植治疗重型再生障碍性贫血[J].中华血液学杂志,1995,16(10):508-510. 被引量:2
  • 4陈虎,江岷,胡亮钉,王波,闫安文,刘传芳,曹履先,邓春江,刘键.同种异基因外周血干细胞移植后造血功能的快速重建[J].中华内科杂志,1996,35(8):553-554. 被引量:3
  • 5黄晓军.骨髓移植后CMV间质性肺炎[J].国外医学(输血及血液学分册),1996,19(5):282-284. 被引量:3
  • 6Godder K, Eapen M, Laver JH, et al. Autologous hematopoietic stem-celt transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. J Clin Oncol 2004:22(18):3798-3804.
  • 7Hallemeier C, Girgis M, Blum W, et al. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants. Bone Marrow Transplant 2004;10(5): 310-319.
  • 8Heinzelmann F, Ottinger H, Muller CH, et al. Total-body irradiation--role and indications: results from the German Registry for Stem Cell Transplantation (DRST). Strahlenther Onkol 2006: 182(4): 222-230.
  • 9Mamlouk K, Saracino G, Berrym an RB, et al. Modification of the Bu/Cy myeloablative regimen using daily parentera! busulfan: reduced toxicity without the need for pharmacokinetic monitoring. Bone Marrow Transplant 2005: 35(8): 747-754.
  • 10Gil L, Styczynski J, Komarnicki M. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Infection 2007. 35(6): 421-427.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部